Retiring CEO Bresch leaves a legacy of growth at Mylan

Global pharmaceutical company Mylan NV announced its CEO and Board Director Heather Bresch will retire as the company merges with Pfizer Inc. unit Upjohn by the middle of 2020 to form a new company with the EpiPen, Lipitor and Viagra among its products. In 2012, Bresch was the first woman named CEO of a Fortune 500 global pharmaceutical company. During an almost three-decade career at Mylan, she helped transform the company from a 300-employee, $100 million revenue, single-country operation into…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news